Greater Cannabis Company (GCAN) Return on Equity (2017 - 2022)
Greater Cannabis Company's Return on Equity history spans 6 years, with the latest figure at 0.85% for Q3 2022.
- For Q3 2022, Return on Equity fell 355.0% year-over-year to 0.85%; the TTM value through Sep 2022 reached 0.85%, down 355.0%, while the annual FY2021 figure was 1.61%, 57.0% up from the prior year.
- Return on Equity reached 0.85% in Q3 2022 per GCAN's latest filing, down from 1.05% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 4.57% in Q2 2021 to a low of 0.46% in Q1 2021.
- Average Return on Equity over 5 years is 1.63%, with a median of 1.4% recorded in 2020.
- Peak YoY movement for Return on Equity: surged 379bps in 2021, then plummeted -355bps in 2022.
- A 5-year view of Return on Equity shows it stood at 1.31% in 2018, then increased by 15bps to 1.51% in 2019, then increased by 29bps to 1.94% in 2020, then dropped by -16bps to 1.62% in 2021, then tumbled by -48bps to 0.85% in 2022.
- Per Business Quant, the three most recent readings for GCAN's Return on Equity are 0.85% (Q3 2022), 1.05% (Q2 2022), and 1.17% (Q1 2022).